Link between early antibiotic exposure and weight gain in young children
A study conducted within the National Patient Centered Clinical Research Network (PCORnet) has found that antibiotic use at less than 24 months of age was associated with slightly higher body weight at 5 years of age.

Antibiotic overuse has been a major population health concern, primarily due to the dangers of increasing antibiotic resistance but, recently, interest in antibiotics’ effect on weight has emerged. Antibiotics disrupt the natural balance of intestinal bacteria or gut microbiome. Because the microbiome has important effects on the body’s metabolism and how food is digested, researchers have hypothesised that changes in weight might occur with microbiome disruptions.
PCORnet is an innovative research network that facilitates research across healthcare institutions through use of a process whereby each institution organises their data from electronic health records into a common form. The network also uses a variety of important innovations to protect patient privacy. Studies conducted in PCORnet also incorporate patient views in the design and conduct of the study.
This study used a sample of over 360,000 children from 35 institutions over the country. Researchers examined the relationship between antibiotic use among children less than two years old and their weight at around five years old, analysing such factors as: diagnosis of chronic conditions, number of antibiotic prescriptions given to children, and the specific types of antibiotics given.
Results show a small effect of antibiotic use and weight gain – less than a pound difference in weight for children of average height and weight receiving 4 or more courses of antibiotics, compared to children who received none.
“While this small difference in weight might not be important for individual decisions regarding antibiotic prescribing by doctors and parents, these data may serve, in a small way, to further encourage efforts to decrease antibiotic use. The ability to conduct research on large, diverse populations in networks like PCORnet provides critical opportunities to examine important research questions, no matter the outcome.” said Jason Block, lead author and Associate Professor of Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School.
The study was published in the journal Pediatrics.
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Looking for chemical products? Let suppliers reach out to you!
2026-06-26
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
India Raises Cancer Drug Price Caps by 50%
Recommend Reading
-
Sun Pharma’s Winning Formula: Precision Over Expansion
-
Roche Keeps German Diagnostics Investment
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
BASF to Shut Down Hydrosulfites Production in Ludwigshafen
-
ECHEMI High Quality Inquiries (28 Jul- 1 Aug)
-
Ammonium Sulfate Market Trend Weakens and Declines (10.23-10.29)
-
Marinela Makeup Partners with FasterCapital to Scale Its Vegan Beauty Line
-
Wanhua Restarts Fujian Plant After Maintenance TDI Prices Soar as Exports Surge 83 Percent